Neuroprotective and Neurological/Cognitive Enhancement Effects of Curcumin after Brain Ischemia Injury with Alzheimer's Disease Phenotype
- PMID: 30545070
- PMCID: PMC6320958
- DOI: 10.3390/ijms19124002
Neuroprotective and Neurological/Cognitive Enhancement Effects of Curcumin after Brain Ischemia Injury with Alzheimer's Disease Phenotype
Abstract
In recent years, ongoing interest in ischemic brain injury research has provided data showing that ischemic episodes are involved in the development of Alzheimer's disease-like neuropathology. Brain ischemia is the second naturally occurring neuropathology, such as Alzheimer's disease, which causes the death of neurons in the CA1 region of the hippocampus. In addition, brain ischemia was considered the most effective predictor of the development of full-blown dementia of Alzheimer's disease phenotype with a debilitating effect on the patient. Recent knowledge on the activation of Alzheimer's disease-related genes and proteins-e.g., amyloid protein precursor and tau protein-as well as brain ischemia and Alzheimer's disease neuropathology indicate that similar processes contribute to neuronal death and disintegration of brain tissue in both disorders. Although brain ischemia is one of the main causes of death in the world, there is no effective therapy to improve the structural and functional outcomes of this disorder. In this review, we consider the promising role of the protective action of curcumin after ischemic brain injury. Studies of the pharmacological properties of curcumin after brain ischemia have shown that curcumin has several therapeutic properties that include anti-excitotoxic, anti-oxidant, anti-apoptotic, anti-hyperhomocysteinemia and anti-inflammatory effects, mitochondrial protection, as well as increasing neuronal lifespan and promoting neurogenesis. In addition, curcumin also exerts anti-amyloidogenic effects and affects the brain's tau protein. These results suggest that curcumin may be able to serve as a potential preventive and therapeutic agent in neurodegenerative brain disorders.
Keywords: Alzheimer’s disease; amyloid; apoptosis; autophagy; brain ischemia; curcumin; genes; mitophagy; neurodegeneration; tau protein.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Post-Ischemic Brain Neurodegeneration in the Form of Alzheimer's Disease Proteinopathy: Possible Therapeutic Role of Curcumin.Nutrients. 2022 Jan 7;14(2):248. doi: 10.3390/nu14020248. Nutrients. 2022. PMID: 35057429 Free PMC article. Review.
-
Substantiation for the Use of Curcumin during the Development of Neurodegeneration after Brain Ischemia.Int J Mol Sci. 2020 Jan 14;21(2):517. doi: 10.3390/ijms21020517. Int J Mol Sci. 2020. PMID: 31947633 Free PMC article. Review.
-
Ischemia-Reperfusion Programming of Alzheimer's Disease-Related Genes-A New Perspective on Brain Neurodegeneration after Cardiac Arrest.Int J Mol Sci. 2024 Jan 20;25(2):1291. doi: 10.3390/ijms25021291. Int J Mol Sci. 2024. PMID: 38279289 Free PMC article.
-
Curcumin Ameliorates Neuroinflammation, Neurodegeneration, and Memory Deficits in p25 Transgenic Mouse Model that Bears Hallmarks of Alzheimer's Disease.J Alzheimers Dis. 2017;60(4):1429-1442. doi: 10.3233/JAD-170093. J Alzheimers Dis. 2017. PMID: 29036814 Free PMC article.
-
Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer's disease.Br J Nutr. 2016 Feb 14;115(3):449-65. doi: 10.1017/S0007114515004687. Epub 2015 Dec 14. Br J Nutr. 2016. PMID: 26652155 Review.
Cited by
-
Ischemia as a common trigger for Alzheimer's disease.Front Aging Neurosci. 2022 Sep 26;14:1012779. doi: 10.3389/fnagi.2022.1012779. eCollection 2022. Front Aging Neurosci. 2022. PMID: 36225888 Free PMC article.
-
Understanding cellular senescence: pathways involved, therapeutics and longevity aiding.Cell Cycle. 2023 Oct;22(20):2324-2345. doi: 10.1080/15384101.2023.2287929. Epub 2023 Dec 15. Cell Cycle. 2023. PMID: 38031713 Free PMC article. Review.
-
Anti-allodynic effect induced by curcumin in neuropathic rat is mediated through the NO-cyclic-GMP-ATP sensitive K+ channels pathway.BMC Complement Med Ther. 2020 Mar 14;20(1):83. doi: 10.1186/s12906-020-2867-z. BMC Complement Med Ther. 2020. PMID: 32171311 Free PMC article.
-
AR ubiquitination induced by the curcumin analog suppresses growth of temozolomide-resistant glioblastoma through disrupting GPX4-Mediated redox homeostasis.Redox Biol. 2020 Feb;30:101413. doi: 10.1016/j.redox.2019.101413. Epub 2019 Dec 26. Redox Biol. 2020. PMID: 31896509 Free PMC article.
-
Functional Nutrition as Integrated Intervention for In- and Outpatient with Schizophrenia.Curr Neuropharmacol. 2023;21(12):2409-2423. doi: 10.2174/1570159X21666230322160259. Curr Neuropharmacol. 2023. PMID: 36946488 Free PMC article.
References
-
- Gemmell E., Bosomworth H., Allan L., Hall R., Khundakar A., Oakley A.E., Deramecourt V., Polvikoski T.M., O’Brien J.T., Kalaria R.N. Hippocampal neuronal atrophy and cognitive function in delayed poststroke and aging-related dementias. Stroke. 2012;43:808–814. doi: 10.1161/STROKEAHA.111.636498. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous